Brought to you by 
CardioInsight Technologies brings in $7.5mm through its Series C venture round
29 Sep 2020
Executive Summary
CardioInsight Technologies Inc. has raised $7.5mm through its Series C venture round to 14 new and current shareholders. The company will use the money for clinical development and commercialization activities for its ECVUE electrocardiographic mapping device, which recently received the CE Mark and should gain FDA approval in the coming months.
Deal Industry
- Medical Devices
-
Medical Devices
- Monitoring Equipment & Devices
-
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
CardioInsight Technologies brings in $7.5mm through its Series C venture round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice